Jonathan Krell

5.2k citations

126 papers · 2.6k indexed · h-index 29

Impact in

Cancer Research top 1%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Cancer Genomics and Diagnostics
Oncology top 5%
- Pancreatic and Hepatic Oncology Research
- Cancer Cells and Metastasis

Papers in ⓘ

Cancer Research 51
- MicroRNA in disease regulation 26
- Cancer-related molecular mechanisms research 14
- Cancer Genomics and Diagnostics 13
Reproductive Medicine 21
- Ovarian cancer diagnosis and treatment 20

Co-authors: Justin Stebbing (54 shared papers)Adam E. Frampton (46 shared papers)Leandro Castellano (32 shared papers)Long R. Jiao (15 shared papers)Loredana Pellegrino (10 shared papers)Jimmy Jacob (11 shared papers)Victoria Harding (10 shared papers)Mark P. Lythgoe (22 shared papers)
Journals: Journal of Clinical Oncology (8 papers)Annals of Oncology (7 papers)Oncotarget (6 papers)Future Oncology (6 papers)Expert Review of Anticancer Therapy (4 papers)
Partner nations: United Kingdom Italy United States

In The Last Decade

Jonathan Krell

123 papers receiving 2.6k citations

Peers

Countries citing papers authored by Jonathan Krell

Since Specialization

Citations

This map shows the geographic impact of Jonathan Krell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan Krell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan Krell more than expected).

Fields of papers citing papers by Jonathan Krell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan Krell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan Krell. The network helps show where Jonathan Krell may publish in the future.

Co-authors

The 25 scholars most cited alongside Jonathan Krell, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jonathan Krell Line = papers co-authored together Jonathan Krell links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 126 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Patient‐derived xenografts for individualized care in advanced sarcoma Cancer ·Justin Stebbing, Keren Paz, Gary K. Schwartz, Leonard H. Wexler, Robert G. Maki, Raphael E. Pollock, Ronnie Morris, Richard Cohen, Arjun Shankar, Glen Blackman, Victoria Harding, David Vásquez, Jonathan Krell, Daniel Ciznadija, Amanda Katz, David Sidransky	2014	120
2	Glypican-1 is enriched in circulating-exosomes in pancreatic cancer and correlates with tumor burden Oncotarget ·Adam E. Frampton, Mireia Mato Prado, Elena López‐Jiménez, Ana Belen Fajardo-Puerta, Zaynab Jawad, Phillip Lawton, Elisa Giovannetti, Nagy Habib, Leandro Castellano, Justin Stebbing, Jonathan Krell, Long R. Jiao	2018	120
3	MicroRNAs Targeting Oncogenes Are Down-Regulated in Pancreatic Malignant Transformation from Benign Tumors PLoS ONE ·Long R. Jiao, Adam E. Frampton, Jimmy Jacob, Loredana Pellegrino, Jonathan Krell, Georgios Giamas, Nicole Tsim, Panagiotis Vlavianos, Patrizia Cohen, Raida Ahmad, Andreas Keller, Nagy Habib, Justin Stebbing, Leandro Castellano	2012	111
4	TGF-β induces miR-100 and miR-125b but blocks let-7a through LIN28B controlling PDAC progression Nature Communications ·Silvia Ottaviani, Justin Stebbing, Adam E. Frampton, Sladjana Zagorac, Jonathan Krell, Alexander de Giorgio, Sara Maria David Trabulo, Van T.M. Nguyen, Luca Magnani, Hugang Feng, Elisa Giovannetti, Niccola Funel, Thomas M. Gress, Long R. Jiao, Ylenia Lombardo, Nicholas R. Lemoine, Christopher Heeschen, Leandro Castellano	2018	101
5	Myocardial MiR-30 downregulation triggered by doxorubicin drives alterations in β-adrenergic signaling and enhances apoptosis Cell Death and Disease ·Laura Roca-Alonso, Leandro Castellano, Adam Mills, Aleksandra Dąbrowska, Markus B. Sikkel, Loredana Pellegrino, Jake Jacob, Adam E. Frampton, Jonathan Krell, R. Charles Coombes, Siân E. Harding, Alexander R. Lyon, Justin Stebbing	2015	100
6	miR-23b regulates cytoskeletal remodeling, motility and metastasis by directly targeting multiple transcripts Nucleic Acids Research ·Loredana Pellegrino, Justin Stebbing, Vania Braga, Adam E. Frampton, Jimmy Jacob, Lakjaya Buluwela, Long R. Jiao, Manikandan Periyasamy, Chris D. Madsen, Matthew Caley, Silvia Ottaviani, Laura Roca-Alonso, Mona El‐Bahrawy, R. Charles Coombes, Jonathan Krell, Leandro Castellano	2013	96
7	miR‐515‐5p controls cancer cell migration through MARK 4 regulation EMBO Reports ·Olivier E. Pardo, Leandro Castellano, Catriona Munro, Yili Hu, Francesco Mauri, Jonathan Krell, Romain Lara, Filipa G. Pinho, Thameenah Choudhury, Adam E. Frampton, Loredana Pellegrino, Dmitry Pshezhetskiy, Yulan Wang, Jonathan Waxman, Michael J. Seckl, Justin Stebbing	2016	94
8	microRNAs with prognostic significance in pancreatic ductal adenocarcinoma: A meta-analysis European Journal of Cancer ·Adam E. Frampton, Jonathan Krell, Nigel B. Jamieson, Tamara Gall, Elisa Giovannetti, Niccola Funel, Mireia Mato Prado, Daniel Krell, Nagy Habib, Leandro Castellano, Long R. Jiao, Justin Stebbing	2015	84
9	Reduced Dissemination of Circulating Tumor Cells With No-Touch Isolation Surgical Technique in Patients With Pancreatic Cancer JAMA Surgery ·Tamara Gall, Jimmy Jacob, Adam E. Frampton, Jonathan Krell, Charis Kyriakides, Leandro Castellano, Justin Stebbing, Long R. Jiao	2014	70
10	The Efficacy of Axillary Ultrasound in the Detection of Nodal Metastasis in Breast Cancer American Journal of Roentgenology ·Belinda Lee, Adrian Lim, Jonathan Krell, Keshthra Satchithananda, R. Charles Coombes, Jacqueline S. Lewis, Justin Stebbing	2013	69
11	Downregulation of microRNA-515-5p by the Estrogen Receptor Modulates Sphingosine Kinase 1 and Breast Cancer Cell Proliferation Cancer Research ·Filipa G. Pinho, Adam E. Frampton, João Nunes, Jonathan Krell, Heba Alshaker, Jimmy Jacob, Loredana Pellegrino, Laura Roca-Alonso, Alexander de Giorgio, Victoria Harding, Jonathan Waxman, Justin Stebbing, Dmitri Pchejetski, Leandro Castellano	2013	67
12	Growth Arrest-Specific Transcript 5 Associated snoRNA Levels Are Related to p53 Expression and DNA Damage in Colorectal Cancer PLoS ONE ·Jonathan Krell, Adam E. Frampton, Reza Mirnezami, Victoria Harding, Alex de Giorgio, Laura Roca Alonso, Patrizia Cohen, Silvia Ottaviani, Teresa Colombo, Jimmy Jacob, Loredana Pellegrino, Gordon F. Buchanan, Justin Stebbing, Leandro Castellano	2014	66
13	Emerging Roles of Competing Endogenous RNAs in Cancer: Insights from the Regulation of PTEN Molecular and Cellular Biology ·Alexander de Giorgio, Jonathan Krell, Victoria Harding, Justin Stebbing, Leandro Castellano	2013	63
14	Maximal-Effort Cytoreductive Surgery for Ovarian Cancer Patients with a High Tumor Burden: Variations in Practice and Impact on Outcome Annals of Surgical Oncology ·Marcia Hall, Konstantinos Savvatis, Katherine Nixon, Maria Kyrgiou, Kuhan Hariharan, Malcolm Padwick, Owen Owens, Paula Cunnea, Jeremy Campbell, Alan Farthing, Richard Stümpfle, Ignacio Vazquez, Neale Watson, Jonathan Krell, Hani Gabra, Gordon Rustin, Christina Fotopoulou	2019	54
15	Viable circulating tumour cell detection using multiplex RNA in situ hybridisation predicts progression-free survival in metastatic breast cancer patients British Journal of Cancer ·Rachel Payne, Feng Wang, Nan Su, Jonathan Krell, Alexis Zebrowski, Ernesto Yagüe, X-J Ma, Yi Luo, R. Charles Coombes	2012	54
16	Rechallenging with anthracyclines and taxanes in metastatic breast cancer Nature Reviews Clinical Oncology ·Carlo Palmieri, Jonathan Krell, Colin R. James, Catherine Harper‐Wynne, Vivek Misra, Susan Cleator, David Miles	2010	52
17	Integrated molecular analysis to investigate the role of microRNAs in pancreatic tumour growth and progression The Lancet ·Adam E. Frampton, Leandro Castellano, Teresa Colombo, Elisa Giovannetti, Jonathan Krell, Jimmy Jacob, Loredana Pellegrino, Laura Roca-Alonso, Niccola Funel, Tamara Gall, Raida Ahmad, Nagy Habib, Thomas Knösel, Justin Stebbing, Long R. Jiao	2015	51
18	Cancer Therapy Approval Timings, Review Speed, and Publication of Pivotal Registration Trials in the US and Europe, 2010-2019 JAMA Network Open ·Mark P. Lythgoe, Aakash Desai, Bishal Gyawali, Philip Savage, Jonathan Krell, Jeremy L. Warner, Ali Raza Khaki	2022	50
19	IDH Mutations in Tumorigenesis and Their Potential Role As Novel Therapeutic Targets Future Oncology ·Daniel Krell, Paul Mulholland, Adam E. Frampton, Jonathan Krell, Justin Stebbing, Chiara Bardella	2013	48
20	TP53 regulates miRNA association with AGO2 to remodel the miRNA–mRNA interaction network Genome Research ·Jonathan Krell, Justin Stebbing, Claudia Carissimi, Aleksandra Dąbrowska, Alexander de Giorgio, Adam E. Frampton, Victoria Harding, Valerio Fulci, Giuseppe Macino, Teresa Colombo, Leandro Castellano	2015	43

About Jonathan Krell

Jonathan Krell is a scholar working on Cancer Research, Reproductive Medicine, Oncology, Biotechnology and Obstetrics and Gynecology, having authored 126 papers that have together received 2.6k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (26 papers), Ovarian cancer diagnosis and treatment (20 papers), Pancreatic and Hepatic Oncology Research (14 papers), Cancer-related molecular mechanisms research (14 papers), Cancer Genomics and Diagnostics (13 papers), Cancer Cells and Metastasis (10 papers), Economic and Financial Impacts of Cancer (9 papers) and Circular RNAs in diseases (8 papers). The work is most often cited by research in Cancer Research (1.3k citations), Oncology (814 citations), Molecular Biology (1.4k citations), Reproductive Medicine (169 citations) and Pathology and Forensic Medicine (168 citations). Jonathan Krell has collaborated with scholars based in United Kingdom, Italy and United States. Frequent co-authors include Justin Stebbing, Adam E. Frampton, Leandro Castellano, Long R. Jiao, Loredana Pellegrino, Jimmy Jacob, Victoria Harding, Mark P. Lythgoe, Elisa Giovannetti and R. Charles Coombes. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Oncotarget, Future Oncology and Expert Review of Anticancer Therapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact